[HTML][HTML] Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis
DM Ouweneel, JV Schotborgh, J Limpens… - Intensive care …, 2016 - Springer
Purpose Veno-arterial extracorporeal life support (ECLS) is increasingly used in patients
during cardiac arrest and cardiogenic shock, to support both cardiac and pulmonary …
during cardiac arrest and cardiogenic shock, to support both cardiac and pulmonary …
Stent thrombosis: a clinical perspective
BE Claessen, JPS Henriques, FA Jaffer… - JACC: Cardiovascular …, 2014 - jacc.org
The invention of intracoronary stents greatly increased the safety and applicability of
percutaneous coronary interventions. At this time,> 1 million coronary stent implantations are …
percutaneous coronary interventions. At this time,> 1 million coronary stent implantations are …
[HTML][HTML] Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group
Mechanical circulatory support represents an evolving field of clinical research and practice.
Currently, several cardiac assist devices have been developed but, among different …
Currently, several cardiac assist devices have been developed but, among different …
Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction
DM Ouweneel, E Eriksen, KD Sjauw… - Journal of the American …, 2017 - jacc.org
Background: Despite advances in treatment, mortality in acute myocardial infarction (AMI)
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …
Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial
JPS Henriques, LP Hoebers, T Råmunddal… - Journal of the American …, 2016 - jacc.org
Abstract Background: In 10% to 15% of patients with ST-segment elevation myocardial
infarction (STEMI), concurrent coronary chronic total occlusion (CTO) in a non–infarct …
infarction (STEMI), concurrent coronary chronic total occlusion (CTO) in a non–infarct …
Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury
L Timmers, JPS Henriques, DPV de Kleijn… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to examine whether exenatide is capable of reducing
myocardial infarct size. Background: Exenatide is a glucagon-like peptide (GLP)-1 analogue …
myocardial infarct size. Background: Exenatide is a glucagon-like peptide (GLP)-1 analogue …
Impella support for acute myocardial infarction complicated by cardiogenic shock: matched-pair iabp-shock II trial 30-day mortality analysis
B Schrage, K Ibrahim, T Loehn, N Werner, JM Sinning… - Circulation, 2019 - Am Heart Assoc
Background: Percutaneous mechanical circulatory support devices are increasingly used in
acute myocardial infarction complicated by cardiogenic shock (AMI-CS), despite limited …
acute myocardial infarction complicated by cardiogenic shock (AMI-CS), despite limited …
Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary …
SZH Rittersma, AC van der Wal, KT Koch, JJ Piek… - Circulation, 2005 - Am Heart Assoc
Background—Acute ST-elevation myocardial infarction (STEMI) is caused by sudden
occlusive coronary thrombosis, after plaque disruption; however, a considerable time …
occlusive coronary thrombosis, after plaque disruption; however, a considerable time …
Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of …
TP van de Hoef, MA van Lavieren… - Circulation …, 2014 - Am Heart Assoc
Background—Discordance between fractional flow reserve (FFR) and coronary flow velocity
reserve (CFVR) may reflect important coronary pathophysiology but usually remains …
reserve (CFVR) may reflect important coronary pathophysiology but usually remains …
A Prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial) …
SR Dixon, JPS Henriques, L Mauri, K Sjauw… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: We sought to evaluate the safety and feasibility of the Impella 2.5 system
(Abiomed Inc., Danvers, Massachusetts) in patients undergoing high-risk percutaneous …
(Abiomed Inc., Danvers, Massachusetts) in patients undergoing high-risk percutaneous …